Hormone replacement therapy in gynecologic cancer survivors: why not?
about
Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleedingEfficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma.Estrogen therapy in gynecological cancer survivors.Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients.Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.
P2860
Hormone replacement therapy in gynecologic cancer survivors: why not?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hormone replacement therapy in gynecologic cancer survivors: why not?
@en
Hormone replacement therapy in gynecologic cancer survivors: why not?
@nl
type
label
Hormone replacement therapy in gynecologic cancer survivors: why not?
@en
Hormone replacement therapy in gynecologic cancer survivors: why not?
@nl
prefLabel
Hormone replacement therapy in gynecologic cancer survivors: why not?
@en
Hormone replacement therapy in gynecologic cancer survivors: why not?
@nl
P2093
P1433
P1476
Hormone replacement therapy in gynecologic cancer survivors: why not?
@en
P2093
Amanda Nickles Fader
Jennifer Ducie
Modupe Agueh
Okechukwu Ibeanu
Susan C Modesitt
Vivian von Gruenigen
P304
P356
10.1016/J.YGYNO.2011.03.012
P407
P577
2011-04-06T00:00:00Z